Skip to content

Massachusetts · Nonprofit

SECUREBIO INC

SECUREBIO INC (Massachusetts) receives grants from 11 organizations whose IRS filings report $6,315,673 to it, the largest being GOOD VENTURES FOUNDATION ($3,557,937). 2 of them have funded it in more than one year.

Revenue FY2024
$7.3M
Funders on record
11
Grants received
$6.3M
Net assets
$7.8M
2/11 repeat funderspeak grant-dependency 81%
01What it does

What Securebio Inc does

Mission

To reduce catastrophic risks from novel biotechnologies by conducting research on pandemic prevention, detection, and mitigation.

As stated on its FY2024 Form 990.

Programs

  1. As part of its work on the Nucleic Acid Observatory NAO project, the organization runs experiments to detect metagenomic sequences in wasterwater, with the ultimate aim of detecting new diseases before they grow exponentially in the community. In 2024, The NAO team conducted real-world biosurveillance of metropolitan sewage and airplane wastewater samples from selected US airports. It expects to scale its detection efforts in 2025.

    $1,454,990 spent
    43% of program spending
  2. As part of its SecureDNA project, the organization continued to make significant progress in 2024 on its gene synthesis screening software. The team released an alpha version and prepared for a public beta launch. This free software offers best-in-class performance in screening criteria and runs against a continuously updated hazard database. SecureDNA uniquely integrates with both vendor order flows and benchtop synthesizers. The organization successfully tested with major manufacturers and collaborated with leading gene synthesis companies. Two papers were prepared for submission to peer-reviewed journals, one on the screening system and another on its cryptographic architecture. These advancements further the organization's goal of securely monitoring synthetic DNA orders against various public health hazards.

    $1,135,237 spent
    34% of program spending
  3. The organization is developing measurement tools to assess AI systems' potential contribution to global catastrophic biological risks and creating mitigation strategies for when AI capabilities cross specific risk thresholds. Working with government and industry partners, they aim to de-risk upcoming AI model releases against severe biological hazards. The team has already published a pre-print on biorisks associated with model weight proliferation in Large Language Models, garnering major media attention. Their ongoing projects include research on risks from frontier models, developing benchmarks to evaluate large language models' biosecurity-relevant capabilities, creating task-based assessments for frontier systems' autonomous capabilities, and implementing technical interventions for risk mitigation, such as model unlearning of dual-use biological concepts and enhancing adversarial robustness against dual-use input prompts.

    $748,527 spent$326,249 earned by the program
    22% of program spending
  4. The organization focuses on pandemic-proof personal protective equipment PPE that reliably shields essential workers against highly infectious agents without requiring fit-testing, ensuring the maintenance of critical infrastructure during pandemics. To enhance the availability and accessibility of this crucial equipment, the organization has undertaken several key initiatives. These include mapping critical infrastructure and essential workers, identifying cost-reduction strategies, advocating for public funds to build and maintain stockpiles, and exploring market mechanisms to support government efforts in stockpiling pandemic-proof PPE. Through these activities, the organization aims to strengthen pandemic preparedness and protect those who must continue working during health crises.

    $47,305 spent
    1% of program spending
  5. As part of its work on the FAR-UVC project, the organization conducted an in-depth examination of the safety of far-UVC germicidal light throughout 2023. This comprehensive study involved convening a group of experts for both in-person and remote workshops over a 12-month period. The culmination of this extensive research was the release of a major paper on far-UVC safety, effectively concluding the organization's work on this project. While the organization designed a clinical study to further investigate the application of far-UVC technology, it determined that executing such a trial was not feasible given the available resources. This decision marked the completion of the organization's active involvement in the FAR-UVC research initiative.

The 5 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $3,386,059.

02The organization over time

The organization over time

Each line starts at 100 in 2022, so what you read is the shape rather than the size: 150 means half as much again as 2022, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20222022 Revenue 100 ($3.4M) Expenses 100 ($186k) Net assets 100 ($3.2M)2023 Revenue 126 ($4.3M) Expenses 1532 ($2.9M) Net assets 145 ($4.7M)2024 Revenue 213 ($7.3M) Expenses 2283 ($4.3M) Net assets 240 ($7.8M)
202220232024
Revenue (213)Expenses (2283)Net assets (240)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2023 to 2024, from $4.9M to $8.5M (+74%).

$3.3M
$4.9M
$8.5M
202220232024
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2022
2023
2024
ContributionsProgram revenueInvestmentOther

93% of SECUREBIO INC’s revenue is contributions — more donation-reliant than the typical peer (67% for the typical peer).

This organization
Typical peer · 498 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 0 of the last 3 reported years ran a deficit.

$3.2M
’22
$1.5M
’23
$3.1M
’24
14
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

202220232024
Listed5812
Joined·+3+7
No longer listed·03
03Who funds it

Who funds it, year by year

Grant support over time, funder by funder — shade shows the grant size each year.

5 of 11 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 19% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of SECUREBIO INC’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

SECUREBIO INC leans on a few funders — its largest provides 56% of grant income and the top three 89%; half comes from just 1 funder.

the vertical line marks half of all grant income — 1 funder to its left

56%
largest funder
89%
top three
~3
effective funders

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

Where its funders are

SECUREBIO INC draws 100% of its grant income from funders outside Massachusetts, across 1 state in all.

CA

Funder states come from each funder’s own filing. $1.2M arriving through sponsors registered in 5 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

SECUREBIO INC runs a healthier operating margin than three-quarters of the 482 science & tech nonprofits its size.

Operating margin42% · top quartile
Months of reserve14.3mo · top quartile
Revenue growth (annualized)46% · top quartile

this organization peer median middle 50% of peers· 482 science & tech nonprofits $1M–$10M, FY2024

Government funding SECUREBIO INC receives

Grants and contracts to this organization from federal (USASpending) and state checkbooks, reconciled to its EIN. $332k on record.

Federal$332k
grants $0contracts $332k
Top agencies
  • Department of Commerce$332k

Federal grants vs contracts are distinguished; state line items keep their reported category. Matched by name + geography (the BMF), so coverage is partial and precision-first.

Organizations like SECUREBIO INC

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Massachusetts

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

80% of spending goes to programs.

Program 80%Management 20%Fundraising 0%

Governance

5
board members
80%
independent
✓Conflict-of-interest policy✓Whistleblower policy–Document retention✓Board reviewed the 990✓Audited financials

Public support

0%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Footprint & structure

Files a return copy in 3 states

IL
MA
DC

Screen this organization

A dated, signed PDF of the compliance screen for SECUREBIO INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds SECUREBIO INC?
SECUREBIO INC (Massachusetts) receives grants from 11 organizations whose IRS filings report $6,315,673 to it, the largest being GOOD VENTURES FOUNDATION ($3,557,937). 2 of them have funded it in more than one year.
How many funders does SECUREBIO INC have?
IRS filings report 11 organizations giving $6,315,673 in grants to SECUREBIO INC, 2 of which have funded it in more than one year.
Who is the largest funder of SECUREBIO INC?
GOOD VENTURES FOUNDATION is the largest funder on record, with $3,557,937 in grants. The full list of funders is on this page.
How can an organization like SECUREBIO INC find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Massachusetts. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2022–2024), and the filings of 11 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing